Transforming-growth-factor-b1	NN
downregulates	VBZ
vascular-endothelial-growth-factor-D	NN
expression	NN
in	IN
human	JJ
lung	NN
fibroblasts	NNS
via	IN
the	DT
Jun-NH2-terminal-kinase	NN
signaling	NN
pathway	NN
.	.

Vascular-endothelial-growth-factor	NN
(	(
VEGF	NN
)	)
-	:
D	NN
,	,
a	DT
member	NN
of	IN
the	DT
VEGF	NN
family	NN
,	,
induces	VBZ
both	CC
angiogenesis	NN
and	CC
lymphangiogenesis	NN
by	IN
activating	VBG
VEGF	NN
receptor-2	NN
(	(
VEGFR-2	NN
)	)
and	CC
VEGFR-3	NN
on	IN
the	DT
surface	NN
of	IN
endothelial	JJ
cells	NNS
.	.

Transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
b1	NN
has	VBZ
been	VBN
shown	VBN
to	TO
stimulate	VB
VEGF-A	NN
expression	NN
in	IN
human	JJ
lung	NN
fibroblast	NN
via	IN
the	DT
Smad3	NN
signaling	NN
pathway	NN
and	CC
to	TO
induce	VB
VEGF-C	NN
in	IN
human	JJ
proximal	JJ
tubular	JJ
epithelial	JJ
cells	NNS
.	.

However	RB
,	,
the	DT
effects	NNS
of	IN
TGF-b1	NN
on	IN
VEGF-D	NN
regulation	NN
are	VBP
unknown	JJ
.	.

To	TO
investigate	VB
the	DT
regulation	NN
of	IN
VEGF-D	NN
,	,
human	JJ
lung	NN
fibroblasts	NNS
were	VBD
studied	VBN
under	IN
pro-fibrotic	JJ
conditions	NNS
in	FW
vitro	FW
and	CC
in	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
lung	NN
tissue	NN
.	.

We	PRP
demonstrate	VBP
that	IN
TGF-b1	NN
downregulates	VBZ
VEGF-D	NN
expression	NN
in	IN
a	DT
dose	NN
-	:
and	CC
time-dependent	JJ
manner	NN
in	IN
human	JJ
lung	NN
fibroblasts	NNS
.	.

This	DT
TGF-b1	NN
effect	NN
can	MD
be	VB
abolished	VBN
by	IN
inhibitors	NNS
of	IN
TGF-b	NN
type	NN
I	CD
receptor	NN
kinase	NN
and	CC
Jun-NH2-terminal-kinase	NN
(	(
JNK	NN
)	)
,	,
but	CC
not	RB
by	IN
Smad3	NN
knockdown	NN
.	.

In	IN
addition	NN
,	,
VEGF-D	NN
knockdown	NN
in	IN
human	JJ
lung	NN
fibroblasts	NNS
induces	VBZ
G1/S	NN
transition	NN
and	CC
promotes	VBZ
cell	NN
proliferation	NN
.	.

Importantly	RB
,	,
VEGF-D	NN
protein	NN
expression	NN
is	VBZ
decreased	VBN
in	IN
lung	NN
homogenates	NNS
from	IN
IPF	NN
patients	NNS
compared	VBN
with	IN
control	NN
lung	NN
.	.

In	IN
IPF	NN
lung	NN
sections	NNS
,	,
fibroblastic	JJ
foci	NNS
show	VBP
very	RB
weak	JJ
VEGF-D	NN
immunoreactivity	NN
,	,
whereas	IN
VEGF-D	NN
is	VBZ
abundantly	RB
expressed	VBN
within	IN
alveolar	JJ
interstitial	JJ
cells	NNS
in	IN
control	NN
lung	NN
.	.

Taken	VBN
together	RB
,	,
our	PRP$
data	NNS
identify	VBP
a	DT
novel	JJ
mechanism	NN
for	IN
downstream	JJ
signal	NN
transduction	NN
induced	VBN
by	IN
TGF-b1	NN
in	IN
lung	NN
fibroblasts	NNS
,	,
through	IN
which	WDT
they	PRP
may	MD
mediate	VB
tissue	NN
remodeling	NN
in	IN
IPF	NN
.	.

